Last reviewed · How we verify
NCT04060693
Device Accuracy of Non-invasive Glucose Measurements in Ethnic Skin
NA trial testing P0.5 in Diabetes Mellitus. Withdrawn.
10 December 2019
Quick facts
| Lead sponsor | RSP Systems A/S |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Start date | 10 December 2019 |
| Primary completion | 10 December 2019 |
| Estimated completion | 10 December 2019 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- P0.5
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
RSP Systems A/S
Who can join
18 and older, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical study has been launched to collect spectral raman data paired with validated glucose reference values in private homes of subjects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04060693
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Other RSP Systems A/S trials
Trials by the same sponsor.
- NCT05851469 — Study of a Non-invasive Glucose Measuring Device · NA · completed
- NCT04518813 — A Study of a Non-invasive Glucose Measuring Device in Out-patient Settings · NA · completed
- NCT03782441 — Study of a Novel Non-invasive Glucose Monitoring Device · NA · completed
- NCT04033042 — Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device and Evaluation of the Instructions f · NA · completed
- NCT04126759 — Calibration of a Non-invasive Glucose Measurement Device and Assessment of Its Performance in the Hypoglycemic Range in · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04060693 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RSP Systems A/S
- Last refreshed: 18 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04060693.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing